MMP13 Gene Metaphyseal anadysplasia type 1 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MMP13 Gene Metaphyseal anadysplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP13 Gene Metaphyseal anadysplasia type 1 NGS Genetic DNA Test gene MMP13
Test Details
Metaphyseal anadysplasia type 1 (MAD1) is a rare genetic disorder characterized by abnormal development of the metaphyses, which are the growing ends of long bones in the body. Mutations in the MMP13 gene have been identified as the cause of MAD1.
NGS (Next-Generation Sequencing) genetic testing is a powerful technique used to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of MAD1, NGS can be used to identify mutations or variations in the MMP13 gene that may be responsible for the disorder.
NGS genetic testing for MAD1 involves collecting a DNA sample, typically through a blood sample or saliva swab, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MMP13 gene. The results of the test can help confirm a diagnosis of MAD1 and provide information about the specific genetic variant involved.
Genetic testing can be helpful in confirming a diagnosis, providing information about disease prognosis, guiding treatment decisions, and offering reproductive options for affected individuals and their families. It is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and implications of genetic testing for MAD1 or any other genetic disorder.
| Test Name | MMP13 Gene Metaphyseal anadysplasia type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MMP13 Gene Metaphyseal anadysplasia type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP13 Gene Metaphyseal anadysplasia type 1 NGS Genetic DNA Test gene MMP13 |
| Test Details |
Metaphyseal anadysplasia type 1 (MAD1) is a rare genetic disorder characterized by abnormal development of the metaphyses, which are the growing ends of long bones in the body. Mutations in the MMP13 gene have been identified as the cause of MAD1. NGS (Next-Generation Sequencing) genetic testing is a powerful technique used to analyze multiple genes simultaneously, providing a comprehensive view of an individual’s genetic makeup. In the context of MAD1, NGS can be used to identify mutations or variations in the MMP13 gene that may be responsible for the disorder. NGS genetic testing for MAD1 involves collecting a DNA sample, typically through a blood sample or saliva swab, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MMP13 gene. The results of the test can help confirm a diagnosis of MAD1 and provide information about the specific genetic variant involved. Genetic testing can be helpful in confirming a diagnosis, providing information about disease prognosis, guiding treatment decisions, and offering reproductive options for affected individuals and their families. It is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and implications of genetic testing for MAD1 or any other genetic disorder. |
